A 69-year-old @entity1 presented with a 6-week history of shortness of breath on exertion, unintentional weight loss, altered bowel habits and lethargy. He was diagnosed with @entity955 2   years previously and started on @entity2643 and @entity1229 . He subsequently reverted to sinus rhythm and his medication was stopped 1   year prior to presentation. He denied history of @entity1374 . On examination, he had a small firm goitre of grade I. His skin was warm and sweaty. Thyroid function tests showed him to be @entity3935 . He was started on @entity5012 20   mg; however, he further became significantly @entity3935 . Given the severity of his presentation and lack of any clinical or biochemical improvement, oral @entity617 30   mg once daily was coadministered. His symptoms subsequently resolved and he became euthyroid. The @entity617 was tapered down and stopped while the @entity5012 was incrementally reduced to 10   mg daily.

XXXX -induced thyrotoxicosis: type 1 or type 2?

@entity1 :: ('9606', 'Species') :: ['man'] @entity2643 :: ('MESH:D000638', 'Chemical') :: ['amiodarone'] @entity3935 :: ('MESH:D013958', 'Disease') :: ['thyrotoxic'] @entity5012 :: ('MESH:D002231', 'Chemical') :: ['carbimazole'] @entity955 :: ('MESH:D001281', 'Disease') :: ['atrial fibrillation'] @entity617 :: ('MESH:D011239', 'Chemical') :: ['prednisolone'] @entity1229 :: ('MESH:D014859', 'Chemical') :: ['warfarin'] @entity1374 :: ('MESH:D013959', 'Disease') :: ['thyroid dysfunction']
@entity2643 :: (MESH:D000638,Chemical) :: ['Amiodarone']
